Virogates
8.44
DKK
+3.94 %
Less than 1K followers
VIRO
First North Denmark
Medical Equipment & Services
Health Care
Overview
Ownership
Investor consensus
+3.94%
+29.45%
-6.22%
-20.38%
-38.39%
+8.21%
-87.7%
-81.76%
-87.2%
Virogates is a medical technology company. Business operations are conducted within the research and development of biomarkers and diagnostic instruments for the healthcare industry. The products are sold under various brands and are used in the identification, analysis, and further treatment of diseases, mainly cardiovascular diseases, cancer, and neurological diseases. The company was established in 2001 and is headquartered in Birkerød.
Read moreMarket cap
65.3M DKK
Turnover
26.66K DKK
Revenue
4.9M
EBIT %
-297.14 %
P/E
-
Dividend yield-%
-
Financial calendar
21.8
2025
Interim report Q2'25
6.11
2025
Interim report Q3'25
All
Research
Press releases
3rd party
ShowingAll content types
ViroGates gives notice to convene an Extraordinary General Meeting on 21 May 2025
ViroGates announces its Q1 report for 2025
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools